Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Lirentelimab for severe and chronic forms of allergic conjunctivitis.
J Allergy Clin Immunol. 2022 Sep;150(3):631-639. doi: 10.1016/j.jaci.2022.03.021. Epub 2022 Apr 4.
J Allergy Clin Immunol. 2022.
PMID: 35390403
Free article.
Clinical Trial.
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group.
Vermeire S, et al.
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798037
Clinical Trial.
Item in Clipboard
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group.
Sandborn WJ, et al.
N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617.
N Engl J Med. 2021.
PMID: 34587385
Clinical Trial.
Item in Clipboard
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group.
Peyrin-Biroulet L, et al.
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798039
Free article.
Clinical Trial.
Item in Clipboard
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J; HIBISCUS Study Group.
Rubin DT, et al.
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27. doi: 10.1016/S2468-1253(21)00338-1. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798036
Clinical Trial.
Item in Clipboard
Convolutional Neural Networks to Assess Steno-Occlusive Disease Using Cerebrovascular Reactivity.
Dasari Y, Duffin J, Sayin ES, Levine HT, Poublanc J, Para AE, Mikulis DJ, Fisher JA, Sobczyk O, Khamesee MB.
Dasari Y, et al. Among authors: levine ht.
Healthcare (Basel). 2023 Aug 8;11(16):2231. doi: 10.3390/healthcare11162231.
Healthcare (Basel). 2023.
PMID: 37628429
Free PMC article.
Item in Clipboard
Investigations of hypoxia-induced deoxyhemoglobin as a contrast agent for cerebral perfusion imaging.
Sayin ES, Schulman J, Poublanc J, Levine HT, Raghavan LV, Uludag K, Duffin J, Fisher JA, Mikulis DJ, Sobczyk O.
Sayin ES, et al. Among authors: levine ht.
Hum Brain Mapp. 2023 Feb 15;44(3):1019-1029. doi: 10.1002/hbm.26131. Epub 2022 Oct 29.
Hum Brain Mapp. 2023.
PMID: 36308389
Free PMC article.
Item in Clipboard
Cite
Cite